|Bid||0.3110 x 3000|
|Ask||0.3300 x 900|
|Day's Range||0.3100 - 0.3499|
|52 Week Range||0.1820 - 6.9360|
|Beta (3Y Monthly)||-1.81|
|PE Ratio (TTM)||N/A|
|Earnings Date||Mar 17, 2017 - Mar 20, 2017|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||4.35|
Amedica Corporation (AMDA) today announced that it has completed the previously-announced sale of its spine business to CTL Medical, a Dallas, TX-based privately held medical device manufacturer, on October 1, 2018, all as more fully described below. As previously announced, Amedica and CTL Medical entered in an asset purchase agreement, dated September 5, 2018, whereby CTL Medical agreed to acquire all of Amedica’s commercial spine business for total consideration of up to $10 million. As a result of the closing, CTL Medical is now the exclusive owner of Amedica’s portfolio of metal and silicon nitride spine products, which are presently sold under the brand names of Taurus, Preference, and Valeo, with access to future silicon nitride spine technologies.
NEW YORK, NY / ACCESSWIRE / September 26, 2018 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive ...
SALT LAKE CITY, Sept. 11, 2018-- Amedica Corporation, a company that develops and commercializes silicon nitride for biomedical applications, announced today that it will host a conference call with Dr. ...
Amedica Corporation (AMDA), a company that develops and commercializes silicon nitride for biomedical applications, today announced the filing of a U.S. patent application for breakthrough research findings that have identified a new property of its proprietary silicon nitride. Amedica investigators led by Dr. Giuseppe Pezzotti, a professor at the Kyoto Institute of Technology (Japan) and consultant to Amedica Corporation, have developed micromeritic silicon nitride powders as well as bulk surfaces that are effective against several strains of commonly prevalent viruses - including Influenza A virus (H1N1), the virus responsible for the 2009 flu pandemic. The research has also identified the surface chemical properties of silicon nitride that contribute to the observed virucidal effect.
Amedica Corporation (AMDA) today announced that it has entered into an asset purchase agreement with CTL Medical, a Dallas, TX-based privately held medical device manufacturer that focuses on the spine implant and instrument market, whereby CTL Medical will acquire all of Amedica’s commercial spine business for total consideration of up to $10 million. The transaction is expected to close in the third quarter of 2018, and is subject to usual and customary due diligence and closing conditions. The agreement will make CTL Medical the exclusive owner of Amedica’s portfolio of metal and silicon nitride spine products, with access to future silicon nitride spine technologies.
Amedica Corporation (AMDA), an innovative biomaterial company that develops and commercializes silicon nitride for biomedical applications, is pleased to announce the successful completion of the first spine fusion surgery using the Valeo C+CSC with Lumen Interbody Fusion Device. The first surgery was performed by Dr. Tarek Elalayli of Nashville, TN. “The implant, consisting of a novel combination of solid and porous silicon nitride, is well-designed, and the surgical implantation was straight forward.
WallStEquities.com revisits the Medical Appliances and Equipment space, which is engaged in the manufacture of medical instruments such as dental and surgical appliances. Under evaluation this morning are these four stocks: EDAP TMS S.A. (NASDAQ: EDAP), PAVmed Inc. (NASDAQ: PAVM), Amedica Corp. (NASDAQ: AMDA), and Avinger Inc. (NASDAQ: AVGR).
Pre-market today, WallStEquities.com scans the following Medical Appliances and Equipment stocks: Amedica Corp. (NASDAQ: AMDA), Avinger Inc. (NASDAQ: AVGR), AxoGen Inc. (NASDAQ: AXGN), and Corindus Vascular Robotics Inc. (NYSE AMER: CVRS).
Amedica Corporation (NASDAQ:AMDA) is a small-cap stock with a market capitalization of US$4.80M. While investors primarily focus on the growth potential and competitive landscape of the small-cap companies, they endRead More...
On Wednesday, May 23, 2018, US markets saw broad based gains with six out of nine sectors finishing the trading sessions in green. This Thursday morning, WallStEquities.com looks at the performance of these four Medical Appliances & Equipment stocks: Abbott Laboratories (NYSE: ABT), ABIOMED Inc. (NASDAQ: ABMD), Align Technology Inc. (NASDAQ: ALGN), and Amedica Corp. (NASDAQ: AMDA).
NEW YORK, NY / ACCESSWIRE / May 9, 2018 / Aralez Pharmaceutical shares sunk on Tuesday after reporting first quarter results, despite a third consecutive quarter of positive adjusted EBITDA. Shares of Amedica had a better day yesterday exploding to a close of over 180% after providing Wall Street with some updates on its clinical study activities. The innovative biomaterial company saw its shares explode after providing an update on its clinical study activities including a Single Center Retrospective Comparative Study and a Multi-Center Retrospective Study.
The latest earnings release Amedica Corporation’s (NASDAQ:AMDA) announced in December 2017 confirmed company earnings became less negative compared to the previous year’s level – great news for investors Below, I’veRead More...
Assessing Amedica Corporation’s (NASDAQ:AMDA) past track record of performance is an insightful exercise for investors. It allows us to reflect on whether or not the company has met or exceedRead More...